Category

Zenabis Press Releases

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update   Vancouver, British Columbia – September 15, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided its monthly operational update for August, 2020. Highlights Shai Altman assumed the role of Zenabis’ Chief Executive Officer on September 1, 2020. The Company shipped approximately 4,700 kg of cannabis in the...
Read More

Zenabis Announces First Shipment to Australia

Zenabis Announces First Shipment to Australia Cannabis Shipment Volume Over First Two Months of Third Quarter ~20% Higher Than Cannabis Shipment Volume Over Entire Second Quarter Vancouver, British Columbia – August 31, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced that its first shipments to Australia from its Zenabis Atholville facility...
Read More

Zenabis Announces Second Quarter 2020 Financial Results

Zenabis Announces Second Quarter 2020 Financial Results   Q2 2020 consolidated net revenue of $27.4 million compared to $19.9 million in Q1 2020 Q2 2020 Adjusted EBITDA of $3.1 million compared to $2.3 million in Q1 2020 Q2 2020 gross margin before fair value on cannabis net revenue of 47.4% compared to 39.7% in Q1...
Read More

ZENABIS GLOBAL INC., ENTERS INTO A PURCHASE AGREEMENT WITH MPX INTERNATIONAL’S WHOLLY-OWNED SUBSIDARY, CANVEDA INC., FOR THE SUPPLY OF CANNABIS FLOWER

ZENABIS GLOBAL INC., ENTERS INTO A PURCHASE AGREEMENT WITH MPX INTERNATIONAL’S WHOLLY-OWNED SUBSIDARY, CANVEDA INC., FOR THE SUPPLY OF CANNABIS FLOWER   TORONTO, ONTARIO, August 12, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) has announced entering into a one year supply agreement for high-quality cannabis flower with Canveda Inc. (“Canveda”), a wholly-owned...
Read More

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update   Vancouver, British Columbia – August 10, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided its monthly operational update for July, 2020. Highlights Zenabis Atholville remains in steady state production, with July cultivation output 5% greater than design capacity. The Company now expects that August international shipments...
Read More

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update Vancouver, British Columbia – July 28, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided a corporate update on its recent activities. Highlights The Company has entered into multiple international supply arrangements and expects to ship 550 kg of dried cannabis in July and August under these arrangements....
Read More

Zenabis Announces Appointment of Permanent Chief Executive Officer Announcement is Result of Successful Executive Search Process Initiated in December of 2019

Zenabis Announces Appointment of Permanent Chief Executive Officer Announcement is Result of Successful Executive Search Process Initiated in December of 2019   Vancouver, British Columbia – July 27, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) announces the appointment of Shai Altman as President and Chief Executive Officer (“CEO”) of the Company, relieving Kevin...
Read More

Zenabis Announces Initial Shipments of 510-Threaded Vaporizer Line

Zenabis Announces Initial Shipments of 510-Threaded Vaporizer Line   Vancouver, British Columbia – July 24, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced initial shipments of its Re-Up 510-Threaded Vaporizer line. This week, Zenabis completed first shipments of this new product line, which is produced at Zenabis Atholville using product cultivated...
Read More

Zenabis Announces Closing of Public Offering of Units

Zenabis Announces Closing of Public Offering of Units   Vancouver, British Columbia – June 25, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce the closing of the previously announced overnight marketed offering of units of Zenabis (“Units”), including the exercise in full of the over-allotment option (together, the “Offering”)....
Read More

Zenabis Announces Pricing of Public Offering of Units and Upsizing of the Offering to $20,493,704 million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES   Zenabis Announces Pricing of Public Offering of Units and Upsizing of the Offering to $20,493,704 million   Vancouver, British Columbia – June 19, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that further...
Read More

Zenabis Announces Public Offering of Units for Proceeds of Approximately $15,000,000 and Extension of Senior Secured Debenture

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES   Zenabis Announces Public Offering of Units for Proceeds of Approximately $15,000,000 and Extension of Senior Secured Debenture   Vancouver, British Columbia – June 18, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that:...
Read More

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update Vancouver, British Columbia – June 16, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided a corporate update on its recent activities. Highlights Zenabis Atholville has commenced cultivation of thirteen new high THC cultivars with commercial roll out of three of the new cultivars expected to occur in...
Read More

Zenabis Files Amended and Restated Interim Financials and MD&A for Q1 2020

Zenabis Files Amended and Restated Interim Financials and MD&A for Q1 2020  Vancouver, British Columbia – June 12, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) announces that following a review by the Company’s auditors, the Company has filed amended and restated interim financial statements and management’s discussion and analysis for the three...
Read More

Zenabis Announces Term Sheet for the Supply of Medical Cannabis to the German Market and Receipt of a License Amendment for Zenabis Stellarton

Zenabis Announces Term Sheet for the Supply of Medical Cannabis to the German Market and Receipt of a License Amendment for Zenabis Stellarton   Vancouver, British Columbia – June 5, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that it has assigned its binding term sheet with Farmako GmbH...
Read More

Zenabis Announces Extension and Partial Conversion of Secured Convertible Notes

Zenabis Announces Extension and Partial Conversion of Secured Convertible Notes Vancouver, British Columbia – June 4, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that it has entered into definitive agreements (the “Note Amending Agreements”) with the holders (the “Noteholders”) of each of the subordinated secured convertible notes originally...
Read More

ZENABIS PROVIDES UPDATE ON ANNUAL MEETING OF SHAREHOLDERS

ZENABIS PROVIDES UPDATE ON ANNUAL MEETING OF SHAREHOLDERS VANCOUVER, British Columbia –  May 26, 2020 – Zenabis Global Inc. (“Zenabis” or the “Company”) announces that, after careful consideration and in accordance with applicable corporate and securities laws and stock exchange rules, it has decided to hold its annual meeting of shareholders at a date in...
Read More

Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License

Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License Vancouver, British Columbia – May 20, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that it has successfully received EU-GMP approval for its Atholville facility and expects to commence commercial export to the...
Read More

Zenabis Announces First Quarter 2020 Financial Results

Zenabis Announces First Quarter 2020 Financial Results Q1 2020 Adjusted EBITDA of $2.3 million compares to an EBITDA loss of $10.4 million in the prior quarter Q1 2020 net cannabis revenue increased 18% to $12.6 million from $10.6 million in Q4 2019 Q1 2020 gross margin on cannabis net revenue of 40% compared to 32%...
Read More

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update Vancouver, British Columbia – April 30, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided a corporate update on its recent activities and the impact of COVID-19 on the market and operations. Highlights: Zenabis Atholville cultivation operations continue at steady-date, and operations are focused on adding a significant...
Read More

Zenabis Announces Amendments to Senior Secured Debenture and Positive Operational Updates

Zenabis Announces Amendments to Senior Secured Debenture and Positive Operational Updates Vancouver, British Columbia – April 23, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that it has signed a definitive agreement (the “Amended and Restated Debenture”) with a syndicate of lenders (collectively, the “Senior Lenders”) amending and restating...
Read More

Zenabis Announces Fourth Quarter and Year End 2019 Financial Results

Zenabis Announces Fourth Quarter and Year End 2019 Financial Results 2019 gross revenue grew 870% to $72.8 million from $7.5 million in 2018 Q4 2019 net cannabis revenue increased 52.4% to $10.8 million from $7.1 million in Q3 2019 2019 gross margin on cannabis net revenue of 46.9%   Vancouver, British Columbia – March 30,...
Read More

Zenabis Provides Corporate Update

Zenabis Provides Corporate Update Vancouver, British Columbia – March 11, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided a corporate update on its recent activities. Kevin Coft, Chief Executive Officer of Zenabis, stated “With our collective efforts, we continue to execute on our plan with a focus to achieve operational excellence...
Read More

Zenabis Provides Cannabis 2.0 Product and Strategy Update   

Zenabis Provides Cannabis 2.0 Product and Strategy Update    “Initial indicative demand from our provincial partners is strong. This will make Zenabis one of the first to market.”   – Kevin Coft, CEO.  Vancouver, British Columbia – February 19, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced details of its cannabis derivative product (“Cannabis 2.0”) strategy and execution, including entering into an agreement with a Canadian beverage manufacturer to produce a range of cannabis-infused beverages.  Highlights: ...
Read More

Zenabis Provides Operations Update and Highlights for December 2019

Zenabis Provides Operations Update and Highlights for December 2019 Vancouver, British Columbia – February 5, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to provide an update on its recent facility construction and licensing activities, sales and marketing highlights and recent cannabis production results. “December 2019 delivered our largest-ever harvest. This...
Read More

Zenabis Provides Operations Update and Highlights for November 2019

Zenabis Provides Operations Update and Highlights for November 2019 Vancouver, British Columbia – January 16, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to provide an update on its recent facility construction and licensing activities and recent cannabis production results. Kevin Coft, Chief Executive Officer of Zenabis, stated, “We have now...
Read More

Zenabis Announces Partial Conversion of Secured Convertible Notes

Zenabis Announces Partial Conversion of Secured Convertible Notes   Vancouver, British Columbia – January 16, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce that the holders (the “Noteholders”) of the subordinated secured convertible notes of the Company (the “Convertible Notes”) have agreed to convert, at a conversion price of...
Read More

Zenabis Announces Appointment of New Chief Financial Officer

 Zenabis Announces Appointment of New Chief Financial Officer   Vancouver, British Columbia – January 2, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced the appointment of Eric Rasmussen as Chief Financial Officer (“CFO”),  replacing Mike Smyth, who is retiring.   Mr. Rasmussen joins Zenabis with extensive senior management experience in publicly-listed...
Read More

Zenabis Announces Receipt of License Amendment of Zenabis Langley for an Additional 69% Increase in Total Annual Capacity

Zenabis Announces Receipt of License Amendment of Zenabis Langley for an Additional 69% Increase in Total Annual Capacity   Vancouver, British Columbia – December 16, 2019 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) is pleased to announce the receipt of the license amendment for Zenabis Langley Part 2A, representing an additional 39,400 kg...
Read More

Zenabis Global Inc. Announces Transition of Chief Executive Officer with Appointment of Kevin Coft

Zenabis Global Inc. Announces Transition of Chief Executive Officer with Appointment of Kevin Coft Former CEO Andrew Grieve will continue to contribute as a Zenabis Board member   Vancouver, British Columbia – December 11, 2019 – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company”) announced today the appointment of Kevin Coft as interim Chief...
Read More

Zenabis Announces Details of Completed Over-Subscribed Rights Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Zenabis Announces Details of Completed Over-Subscribed Rights Offering   Vancouver, British Columbia – December 9, 2019 – Zenabis Global Inc (TSX: ZENA) (“Zenabis” or the “Company”) is pleased to announce that, further to its press release dated November 28, 2019...
Read More
1 2 3 4 6
X